BioNTech's Chief Medical Officer announced on Wednesday that they have started the process of delivering the coronavirus vaccine that they have developed with Pfizer, per Reuters.
"We expect the roll-out of the vaccine in the UK in the next couple of days."
"We have filed for conditional marketing authorisation with the European Medicines Agency (EMA)."
"Decision of the US Food and Drug Administration (FDA) and EMA expected in mid-December."
"In discussions with additional countries over supply contracts."
"Will ship doses in temperature controlled boxes to the UK by ferry or plane."
"Vaccine can last for 5 days in a fridge but only 6 hours while transporting to care homes at 2-8 degrees."
"We will distribute as many doses as we can as quickly as we can to jurisdictions that approve the vaccine."
These comments don't seem to be having a significant impact on market sentiment. As of writing, the S&P 500 Futures were down 0.2% on a daily basis at 3,653.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.